Table 4.
Continuation of the miRNA expression and prognostic factors of ccRCC
| miR-200b | miR-106a | miR-106b | |
|---|---|---|---|
| Low (n = 18) | 43.39(89.17) | 65.14(65.16) | 159.44(171.94) |
| Intermediate (n = 29) | 58.51(98.63) | 110.15(141.57) | 90.68(85.67) |
| High n = 9 | 563.01(1128.21) | 202.94(270.20) | 123.81(100.46) |
| P | 0.01 b | 0.23b | 0.31b |
| Size ≥7 cm (n = 30) | 57.91(97.01) | 79.23(68.51) | 125.34(140.61) |
| Size <7 cm (n = 26) | 162.81(545.59) | 139.51(196.72) | 102.81(92.03) |
| P | 0.36a | 0.766 | 0.58a |
| MVI absent (n = 44) | 55.97(95.09) | 93.38(127.07) | 119.47(126.44) |
| MVI present (n = 12) | 355.35(899.73) | 173.31(213.58) | 94.63(90.02) |
| p | 0.53a | 0.17a | 0.17a |
| Fuhrman’s Grade I e II (n = 32) | 56.44(99.57) | 103.91(158.18) | 135.37(152.50) |
| Fuhrman’s Grade III e IV (n = 24) | 169.48(557.25) | 113.84(143.83) | 101.01(92.55) |
| P | 0.33a | 0.83a | 0.40a |
| pT1–2 (n = 26) | 48.99(94.76) | 67.86(60.49) | 115.03(103.12) |
| pT3–4 (n = 30) | 161.87(521.68) | 143.33(187.99) | 115.59(136.84) |
| P | 0.33a | 0.11a | 0.98a |
| Metastasis Absent (n = 48) | 119.99(0.47) | 117.25(5.12) | 109.83(122.37) |
| Metastasis Present (n = 8) | 50.56(114.07) | 54.21(43.87) | 149.38(113.15) |
| p | 0.66a | 0.38a | 0.50a |
aMann-Whitney test bAnova b Kruskall-Wallis Test
significant p-value are highlighted in bold